Does Rallies show 13F holders for AZTA?

Yes. Rallies tracks hedge fund and 13F ownership data for AZTA, including fund names, share counts, latest tracked quarter, and position changes when available.

Is AZTA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for AZTA. It does not provide personalized investment advice.

AZTA (Azenta, Inc.) Stock Analysis - Hedge Fund Holdings

Azenta, Inc. (AZTA) is a publicly traded Healthcare sector company. As of May 21, 2026, AZTA trades at $18.49 with a market cap of $748.55M and a P/E ratio of -4.85. AZTA moved +5.27% today. Year to date, AZTA is -48.06%; over the trailing twelve months it is -34.31%. Its 52-week range spans $15.93 to $55.64. Analyst consensus is strong buy with an average price target of $30.75. Rallies surfaces AZTA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns AZTA stock?

Hedge funds tracked by Rallies that own AZTA include Centerbook Partners, Bridgewater Associates, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Azenta, Inc..

AZTA Key Metrics

Key financial metrics for AZTA
Metric	Value
Price	$18.49
Market Cap	$748.55M
P/E Ratio	-4.85
EPS	$-3.77
Dividend Yield	0.10%
52-Week High	$55.64
52-Week Low	$15.93
Volume	2.87K
Avg Volume	0
Revenue (TTM)	$596.48M
Net Income	$-173.34M
Gross Margin	44.33%

Top Hedge Funds Holding AZTA

Centerbook Partners holds 29.93K shares of AZTA, changed +15.15% as of Mar 31, 2026.
Bridgewater Associates holds 26.83K shares of AZTA, changed -43.96% as of Mar 31, 2026.
Pinebridge Investments holds 815 shares of AZTA, changed +0.00% as of Jun 30, 2023.

Latest AZTA News

Azenta Cuts FY26 Guidance to $603–621M, Extends Growth Plan to 2029 — May 5, 2026
Azenta Appoints Trey Martin as Multiomics President to Scale Gene Synthesis — Apr 7, 2026
Azenta Drives Turnaround with $550M Cash, $600M Revenue and Kaizen Gains — Mar 6, 2026
Azenta Acquires UK Biocentre for £20.5M, Expands European Biorepository Capabilities — Mar 4, 2026
Azenta Tests FluidX Tubes on EGGS-2 Space Mission to Showcase Consumable Reliability — Feb 9, 2026

Recent AZTA Insider Trades

Cornog William L bought 10.00K (~$163.80K) on May 18, 2026.
Marotta John sold 316 (~$9.29K) on Sep 10, 2025.
Pirogova Olga sold 1.08K (~$30.97K) on Aug 12, 2025.

AZTA Analyst Consensus

4 analysts cover AZTA: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $30.75.

Common questions about AZTA

Who owns AZTA stock?: Hedge funds tracked by Rallies that own AZTA include Centerbook Partners, Bridgewater Associates, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Azenta, Inc..
Does Rallies show 13F holders for AZTA?: Yes. Rallies tracks hedge fund and 13F ownership data for AZTA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is AZTA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for AZTA. It does not provide personalized investment advice.